---
figid: PMC6965019__fnmol-12-00314-g0002
figtitle: TLR-MyD88 signaling pathway contributes to the pathogenesis of multiple
  sclerosis (MS)
organisms:
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Streptococcus pneumoniae
- Porphyromonas gingivalis
- Campylobacter jejuni
- Mycobacterium intracellulare subsp. intracellulare
- Human immunodeficiency virus
- Theilers encephalomyelitis virus
- Human endogenous retrovirus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- herbal medicine
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6965019
filename: fnmol-12-00314-g0002.jpg
figlink: pmc/articles/PMC6965019/figure/F2/
number: F2
caption: The TLR-MyD88 signaling pathway contributes to the pathogenesis of multiple
  sclerosis (MS). The TLR-MyD88 and TLR-TRIF signaling pathways activate dendritic
  cells (DCs), Th17 cells, Th1 cells, and B cells and increase pro-inflammatory cytokine
  secretion. These pathogenic DCs can also promote the activation of Th1 and Th17
  cells. Furthermore, the TLR signaling pathway destroys the blood brain barrier (BBB)
  and increases the expression of BBB-expressed adhesion molecules [ICAM-1 and vascular
  cell adhesion molecules (VCAM)-1] after being stimulated by PAMPs and endogenous
  danger-associated molecular patterns (DAMPs). The activation of these cells and
  the destruction of the BBB aggravate MS.
papertitle: Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis.
reftext: Chao Zheng, et al. Front Mol Neurosci. 2019;12:314.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9230097
figid_alias: PMC6965019__F2
figtype: Figure
redirect_from: /figures/PMC6965019__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6965019__fnmol-12-00314-g0002.html
  '@type': Dataset
  description: The TLR-MyD88 signaling pathway contributes to the pathogenesis of
    multiple sclerosis (MS). The TLR-MyD88 and TLR-TRIF signaling pathways activate
    dendritic cells (DCs), Th17 cells, Th1 cells, and B cells and increase pro-inflammatory
    cytokine secretion. These pathogenic DCs can also promote the activation of Th1
    and Th17 cells. Furthermore, the TLR signaling pathway destroys the blood brain
    barrier (BBB) and increases the expression of BBB-expressed adhesion molecules
    [ICAM-1 and vascular cell adhesion molecules (VCAM)-1] after being stimulated
    by PAMPs and endogenous danger-associated molecular patterns (DAMPs). The activation
    of these cells and the destruction of the BBB aggravate MS.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hand1
  - Nelfcd
  - Ell
  - El1
  - D9Mgc46e
  - Pdpn
  - Alms1
  - Tmed7
  - Ticam2
  - Rnf138
  - Trim69
  - Ticam1
  - NELFCD
  - ELL
  - EPB41
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - TRIM69
  - TICAM1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - dc
  - TH1
  - Su(Tpl)
  - TRAM
  - TRAM
  - Multiple Sclerosis
---
